Systemic Steroid Versus Combined Systemic and Intratympanic Steroid Treatment for Sudden Sensorineural Hearing Loss

2013 ◽  
Vol 24 (2) ◽  
pp. 432-434 ◽  
Author(s):  
Elif Baysal ◽  
Orhan Tunç ◽  
Tekin Baglam ◽  
Cengiz Durucu ◽  
Arzu Oz ◽  
...  
Keyword(s):  
Hearing Loss ◽  
Sensorineural Hearing Loss ◽  
Sudden Sensorineural Hearing Loss ◽  
Steroid Treatment ◽  
Sensorineural Hearing ◽  
Systemic Steroid

Clinical efficacy of initial intratympanic steroid treatment on sudden sensorineural hearing loss with diabetes

2009 ◽  
Vol 141 (5) ◽  
pp. 572-578 ◽  
Author(s):  
Chi-Sung Han ◽  
Jong-Ryul Park ◽  
Sung-Hyun Boo ◽  
Joon-Man Jo ◽  
Kyung-Won Park ◽  
...  
Keyword(s):  
Hearing Loss ◽  
Sensorineural Hearing Loss ◽  
Initial Treatment ◽  
Sudden Sensorineural Hearing Loss ◽  
Steroid Treatment ◽  
Sensorineural Hearing ◽  
Systemic Steroid ◽  
Significant Difference ◽  
Before And After ◽  
Patients With Diabetes

Objective: The purpose of this study is to compare the efficacy of intratympanic steroid injection (ITSI) with that of systemic steroids as an initial treatment of sudden sensorineural hearing loss (SNHL) with diabetes. Study Design: Prospective, nonrandomized multicenter clinical trial. Setting: Multicenter study in Busan and Masan, South Korea. Subjects and Methods: A total of 114 sudden SNHL patients who were diagnosed with diabetes were divided into peroral (PO) group (n = 48), intravenous (IV) group (n = 32), and intratympanic (IT) group (n = 34). In the PO group, prednisolone was used orally for 10 days, per schedule. In the IV group, prednisolone was administered intravenously for seven days, followed by oral administration of tapered doses for another several days. In the IT group, dexamethasone was injected into the tympanic cavity four times within a two-week period. Hearing outcome was assessed before and after the treatment. Results: All groups showed significant improvement with criteria of 15 dB ( P < 0.05). However, there was no significant difference in hearing gain and recovery rate among groups ( P > 0.05). Systemic steroid treatment was stopped for two patients in the IV group and for one in the PO group due to uncontrolled hyperglycemia. However, in the IT group, there were no patients who failed to control their blood sugar level. Conclusion: ITSI is as effective as systemic steroid treatment for sudden SNHL patients with diabetes and it can avoid undesirable side effects. Therefore, we consider ITSI to be a more reasonable alternative as an initial treatment for sudden SNHL patients with diabetes.

scholarly journals Oral steroid treatment for idiopathic sudden sensorineural hearing loss

2015 ◽  
Vol 36 (4) ◽  
pp. 291-296 ◽  
Author(s):  
Wei Chen ◽  
Jui Lee ◽  
Chien Yuan ◽  
Rong Chen
Keyword(s):  
Hearing Loss ◽  
Sensorineural Hearing Loss ◽  
Sudden Sensorineural Hearing Loss ◽  
Steroid Treatment ◽  
Sensorineural Hearing ◽  
Oral Steroid

scholarly journals Combined Intratympanic and Systemic Steroid Therapy for Idiopathic Sudden Sensorineural Hearing Loss

2021 ◽  
Vol 124 (1) ◽  
pp. 35-42
Author(s):  
Yoshihiko Hiraga ◽  
Koichiro Wasano ◽  
Taiji Kawasaki ◽  
Nobuyoshi Tsuzuki ◽  
Sosuke Sahara ◽  
...  
Keyword(s):  
Hearing Loss ◽  
Sensorineural Hearing Loss ◽  
Steroid Therapy ◽  
Sudden Sensorineural Hearing Loss ◽  
Sensorineural Hearing ◽  
Systemic Steroid ◽  
Systemic Steroid Therapy

Sudden sensorineural hearing loss: systemic steroid therapy and the risk of glucocorticoid-induced hyperglycemia

2012 ◽  
Vol 270 (4) ◽  
pp. 1255-1261 ◽  
Author(s):  
Christian Rohrmeier ◽  
Nikola Koemm ◽  
Philipp Babilas ◽  
Philipp Prahs ◽  
Juergen Strutz ◽  
...  
Keyword(s):  
Hearing Loss ◽  
Sensorineural Hearing Loss ◽  
Steroid Therapy ◽  
Sudden Sensorineural Hearing Loss ◽  
Sensorineural Hearing ◽  
Systemic Steroid ◽  
Systemic Steroid Therapy
Sign in / Sign up

Export Citation Format

Share Document